Valiant Organics Ltd (VALIANTORG) — shareholding pattern, promoter holding, financials and share price

About Valiant Organics Ltd (VALIANTORG)

Valiant Organics Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as VALIANTORG and on the BSE under scrip code 540145. Its ISIN is INE565V01010.

Incorporated in 1984, Valiant Organics Ltd manufactures and deals in specialty chemicals and pharma intermediates [1]

Valiant Organics Limited manufactures benzene-based specialty chemicals and is one of the world’s largest producers of chlorophenol derivatives and a leading domestic producer of PNA, anisidines and PAP, supplying dyes, pigments, agrochemicals, pharmaceuticals and specialty chemical customers from six manufacturing units located strategically near western Indian ports, with an aggregate installed capacity of approximately 70,000 MTPA and five Zero Liquid Discharge plants.

Financial performance shows a meaningful recovery: 9M-FY26 consolidated revenue was INR 5,210 million (up ~1.2% YoY) while EBITDA expanded to INR 616 million with an 11.82% margin, driven by improved gross margin, cost control and an exceptional insurance refund of INR 57 million; cumulative results mark a PAT turnaround to INR 175 million after prior year losses, indicating operational resilience and margin restoration.

Listed peers in Specialty Chemicals: Indo Amines Ltd, Amal Ltd, Chemcon Speciality Chemicals Ltd, Jayant Agro Organics Ltd, Chembond Chemicals Ltd, DMCC Speciality Chemicals Ltd.

Valuation & Returns

10 Jul 2026

At ₹270.25 a share on 10 Jul 2026, Valiant Organics Ltd (VALIANTORG) was valued at a price-to-earnings ratio of 22.81x against an industry P/E of 45.11x and a price-to-book of 1.04x on a book value of ₹258.7 per share as of Mar 2025. Solomo computes return on equity of 4.58% and return on capital employed of 6.16% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
22.81x
Industry P/E
45.11x
P/B
1.04x
EPS (TTM)
₹11.85
Book value / share
₹258.7
ROE
4.58%
ROCE
6.16%
ROA
2.81%
Debt / equity
0.34x
Dividend yield
0%
EBITDA margin
13.48%
52-week range
₹195.2 – ₹418.9

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Valiant Organics Ltd (VALIANTORG) reported revenue of ₹739 crore, net profit of ₹33 crore and earnings per share of ₹11.86. That compares with revenue of ₹719 crore and net profit of ₹-3 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹218 crore and net profit ₹16 crore (consolidated).

Consolidated annual results for Valiant Organics Ltd (VALIANTORG), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)1,1531,052723719739
Net profit (₹ cr)128103-8-333
EPS (₹)41.7232.45-3.04-1.3411.86
Compound annual growth for Valiant Organics Ltd (VALIANTORG). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth33.12%4.26%-8.83%-0.59%
Profit growth---59.17%
Stock price CAGR--28%-18%-34%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 37.87% of Valiant Organics Ltd (VALIANTORG) (down 0.02 pp QoQ), foreign institutional investors (FII) hold 0.21%. Market capitalisation was ₹758 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2017.

Largest disclosed public shareholders in Jun 2026: Nikhil Parimal Desai 9.16%, Bhanumati Mohanlal Savla 3.18%, Harsha Mahesh Savadia 2.3%, Bhaveshkumar Bachubhai Mehta 2.29%, Meena Manoj Chheda 1.93%, Mahesh Mathuradas Savadia 1.92%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202637.87%-0.21%-62.13%
Mar 202637.89%-0.28%-62.11%
Dec 202537.89%-0.23%-62.11%
Sep 202537.91%-0.21%-62.09%
Jun 202537.91%-0.21%0%62.09%
Mar 202537.91%-0.37%0%62.09%
Dec 202437.74%-0.82%0%62.26%
Sep 202437.77%0.2%1.33%0.08%62.23%
Every quarter since Mar 2017 Filing data, not investment advice.